ALVO Alvotech

  1. Stocks
  2. Healthcare
  3. NASDAQ: ALVO

Price (delayed)

$3.68

Market cap

$1.15B

P/E Ratio

36.8

Dividend/share

N/A

EPS

$0.1

Enterprise value

$2.43B

?
Relative Growth: Rel. Growth: 74
Relative Strength: Rel. Strength: 6
Relative Valuation: Rel. Valuation: 80
Relative Profitability: Rel. Profitability: 60
Highlights
ALVO's revenue is up by 20% year-on-year and by 2.7% since the previous quarter
The price to earnings (P/E) is 15% lower than the last 4 quarters average of 37.1
ALVO's quick ratio has surged by 135% since the previous quarter but it is down by 27% year-on-year
ALVO's net income has surged by 112% year-on-year but it has dropped by 60% since the previous quarter
ALVO's debt is up by 22% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ALVO

ALVO stock price

How has the Alvotech stock price performed over time
Intraday
17.2%
1 week
7.29%
1 month
4.55%
1 year
-66.02%
YTD
-28.27%
QTD
7.29%

Financial performance

How have Alvotech's revenue and profit performed over time
Revenue
$588.9M
Gross profit
$353.35M
Operating income
$78.21M
Net income
$27.92M
Gross margin
60%
Net margin
4.7%
ALVO's net income has surged by 112% year-on-year but it has dropped by 60% since the previous quarter
ALVO's net margin has soared by 110% YoY but it has plunged by 61% from the previous quarter
ALVO's operating income has surged by 80% since the previous quarter and by 12% year-on-year
ALVO's operating margin has surged by 75% since the previous quarter but it is down by 6% year-on-year

Price vs fundamentals

How does ALVO's price correlate with its fundamentals

Growth

What is Alvotech's growth rate over time

Valuation

What is Alvotech stock price valuation
P/E
36.8
P/B
N/A
P/S
1.95
EV/EBIT
8.49
EV/EBITDA
7.5
EV/Sales
4.12
The EPS has soared by 111% year-on-year but it has dropped by 57% since the previous quarter
The price to earnings (P/E) is 15% lower than the last 4 quarters average of 37.1
The company's equity has shrunk by 61% QoQ but it rose by 31% YoY
The stock's price to sales (P/S) is 94% less than its 5-year quarterly average of 27.4 and 61% less than its last 4 quarters average of 4.3
ALVO's revenue is up by 20% year-on-year and by 2.7% since the previous quarter

Efficiency

How efficient is Alvotech business performance
The ROS has soared by 179% year-on-year and by 23% since the previous quarter
The company's return on invested capital has surged by 167% YoY and by 23% QoQ
The ROA has soared by 110% year-on-year but it has dropped by 62% since the previous quarter

Dividends

What is ALVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALVO.

Financial health

How did Alvotech financials performed over time
The total assets is 16% smaller than the total liabilities
ALVO's quick ratio has surged by 135% since the previous quarter but it is down by 27% year-on-year
The company's current ratio rose by 33% QoQ but it fell by 20% YoY
ALVO's debt to equity has dropped by 77% year-on-year but it is up by 30% since the previous quarter
The company's equity has shrunk by 61% QoQ but it rose by 31% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.